US FDA News: FDA Conditionally Approves First Oral Tablet to Treat Lymphoma in Dogs

The U.S. Food and Drug Administration has conditionally approved Laverdia-CA1 (verdinexor), the first oral tablet for treatment of canine lymphoma.
Read more: FDA Conditionally Approves First Oral Tablet to Treat Lymphoma in Dogs